Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

Affiliations

• ¹ Division of Hematology, Oncology and Blood and Marrow Transplantation, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
• ² University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
• ³ Kaiser Permanente Southern California, Los Angeles, CA, USA.
• ⁴ Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
• ⁵ Department of Radiology and Imaging, Children's Hospital Los Angeles, Los Angeles, CA, USA.